Skip to content
Storytelling Co – Lifestyle
Author:
Aclarion, Inc.
Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine
May 5, 2026
Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption
April 30, 2026
Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan
April 28, 2026
←
Previous Page
1
2
3